 |
What to Do When a Patient Presents With Erectile Dysfunction: Urologic Symptoms in Primary Care CME/CE Author Information and Disclosures Release Date: September 17, 2008; Valid for credit through September 17, 2009 | Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 0.5 ANCC contact hours (None of these credits is in the area of pharmacology) | | To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details. Contents of This CME/CE Activity Legal DisclaimerThe material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Define erectile dysfunction and review steps for evaluating patients who present with erectile dysfunction
- Discuss treatment options for erectile dysfunction, and the circumstances under which a primary care provider should refer the patient
to a specialist
Authors and Disclosures Mathew Oommen, MD
Disclosure: Mathew Oommen, MD, has disclosed no relevant financial relationships. Wayne J.G. Hellstrom, MD, FACS
Disclosure: Wayne J.G. Hellstrom, MD, FACS, has disclosed that he has served as an advisor
or consultant to American Medical Systems, Auxilium, Coloplast, GlaxoSmithKline/Schering-Plough, Indevus, Johnson & Johnson, King-Palatin, Lilly, Pfizer, Plethora, sanofi-aventis, and Solvay. Dr. Hellstrom has also disclosed that he has served as a lecturer for Auxilium, GlaxoSmithKline/Schering-Plough, Johnson & Johnson, Lilly, Pfizer, sanofi-aventis, and Solvay. Additionally, Dr. Hellstrom has disclosed that he has been involved in scientific studies or trials for
GlaxoSmithKline/Schering-Plough and Lilly. Dr. Hellstrom has also disclosed that he has served as an investigator for American Medical Systems, Coloplast, Indevus, Inotek, Lilly, Plethora, and sanofi-aventis. Dr. Hellstrom has also disclosed that he has served as an advisory board member for Theralogix. Laurie E. Scudder, MS, NP-C
Disclosure: Laurie E. Scudder, MS, NP-C, has disclosed that she has no relevant
financial relationships. David McNeel
Disclosure: David McNeel has disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
Medscape is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 0.5 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.
Contact This Provider
|
|
